NAD Homeostasis and NAD-Consuming Enzymes: Implications for Vascular Health

Overview

Journal Antioxidants (Basel)

Date 2023 Feb 25

PMID 36829935

Authors

Roberto Campagna

Arianna Vignini

Affiliations

Soon will be listed here.

Abstract

Nicotinamide adenine dinucleotide (NAD) is a ubiquitous metabolite that takes part in many key redox reactions. NAD biosynthesis and NAD-consuming enzymes have been attracting markedly increasing interest since they have been demonstrated to be involved in several crucial biological pathways, impacting genes transcription, cellular signaling, and cell cycle regulation. As a consequence, many pathological conditions are associated with an impairment of intracellular NAD levels, directly or indirectly, which include cardiovascular diseases, obesity, neurodegenerative diseases, cancer, and aging. In this review, we describe the general pathways involved in the NAD biosynthesis starting from the different precursors, analyzing the actual state-of-art of the administration of NAD precursors or blocking NAD-dependent enzymes as strategies to increase the intracellular NAD levels or to counteract the decline in NAD levels associated with ageing. Subsequently, we focus on the disease-related and age-related alterations of NAD homeostasis and NAD-dependent enzymes in endothelium and the consequent vascular dysfunction, which significantly contributes to a wide group of pathological disorders.

Citing Articles

Role of Nicotinamide in the Pathogenesis of Actinic Keratosis: Implications for NAD/SIRT1 Pathway.

Belardi R, Pacifici F, Cosio T, Lambiase S, Shumak R, Artosi F Biomolecules. 2025; 14(12.

PMID: 39766219 PMC: 11673244. DOI: 10.3390/biom14121512.

Modulation of NRF2/KEAP1 Signaling by Phytotherapeutics in Periodontitis.

Tossetta G, Fantone S, Togni L, Santarelli A, Olivieri F, Marzioni D Antioxidants (Basel). 2024; 13(10).

PMID: 39456522 PMC: 11504014. DOI: 10.3390/antiox13101270.

Erythrocyte nicotinamide adenine dinucleotide concentration is enhanced by systematic sports participation.

Pospieszna B, Kusy K, Slominska E, Zielinski J, Ciekot-Soltysiak M BMC Sports Sci Med Rehabil. 2024; 16(1):216.

PMID: 39407226 PMC: 11476931. DOI: 10.1186/s13102-024-00999-y.

The Multifaceted Role of Endothelial Sirt1 in Vascular Aging: An Update.

Campagna R, Mazzanti L, Pompei V, Alia S, Vignini A, Emanuelli M Cells. 2024; 13(17.

PMID: 39273039 PMC: 11394039. DOI: 10.3390/cells13171469.

Advances in the Synthesis and Physiological Metabolic Regulation of Nicotinamide Mononucleotide.

Zheng C, Li Y, Wu X, Gao L, Chen X Nutrients. 2024; 16(14).

PMID: 39064797 PMC: 11279976. DOI: 10.3390/nu16142354.

References

Wei Z, Chai H, Chen Y, Cheng Y, Liu X . Nicotinamide mononucleotide: An emerging nutraceutical against cardiac aging?. Curr Opin Pharmacol. 2021; 60:291-297. DOI: 10.1016/j.coph.2021.08.006. View

Weiss R, Schilling E, Grahnert A, Kolling V, Dorow J, Ceglarek U . Nicotinamide: a vitamin able to shift macrophage differentiation toward macrophages with restricted inflammatory features. Innate Immun. 2015; 21(8):813-26. DOI: 10.1177/1753425915602545. View

Ferrucci L, Fabbri E . Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty. Nat Rev Cardiol. 2018; 15(9):505-522. PMC: 6146930. DOI: 10.1038/s41569-018-0064-2. View

Berger N . Poly(ADP-ribose) in the cellular response to DNA damage. Radiat Res. 1985; 101(1):4-15. View

Lukasova M, Hanson J, Tunaru S, Offermanns S . Nicotinic acid (niacin): new lipid-independent mechanisms of action and therapeutic potentials. Trends Pharmacol Sci. 2011; 32(12):700-7. DOI: 10.1016/j.tips.2011.08.002. View

Togni L, Mascitti M, Sartini D, Campagna R, Pozzi V, Salvolini E . Nicotinamide N-Methyltransferase in Head and Neck Tumors: A Comprehensive Review. Biomolecules. 2021; 11(11). PMC: 8615955. DOI: 10.3390/biom11111594. View

DAmours D, Desnoyers S, DSilva I, Poirier G . Poly(ADP-ribosyl)ation reactions in the regulation of nuclear functions. Biochem J. 1999; 342 ( Pt 2):249-68. PMC: 1220459. View

Mateuszuk L, Campagna R, Kutryb-Zajac B, Kus K, Slominska E, Smolenski R . Reversal of endothelial dysfunction by nicotinamide mononucleotide via extracellular conversion to nicotinamide riboside. Biochem Pharmacol. 2020; 178:114019. DOI: 10.1016/j.bcp.2020.114019. View

Vida A, Marton J, Miko E, Bai P . Metabolic roles of poly(ADP-ribose) polymerases. Semin Cell Dev Biol. 2016; 63:135-143. DOI: 10.1016/j.semcdb.2016.12.009. View

10.

Pirinen E, Canto C, Jo Y, Morato L, Zhang H, Menzies K . Pharmacological Inhibition of poly(ADP-ribose) polymerases improves fitness and mitochondrial function in skeletal muscle. Cell Metab. 2014; 19(6):1034-41. PMC: 4047186. DOI: 10.1016/j.cmet.2014.04.002. View

11.

Fulco M, Cen Y, Zhao P, Hoffman E, McBurney M, Sauve A . Glucose restriction inhibits skeletal myoblast differentiation by activating SIRT1 through AMPK-mediated regulation of Nampt. Dev Cell. 2008; 14(5):661-73. PMC: 2431467. DOI: 10.1016/j.devcel.2008.02.004. View

12.

Groelly F, Fawkes M, Dagg R, Blackford A, Tarsounas M . Targeting DNA damage response pathways in cancer. Nat Rev Cancer. 2022; 23(2):78-94. DOI: 10.1038/s41568-022-00535-5. View

13.

Zhang H, Dai Y, Zhang C, Omondi A, Ghosh A, Khanra I . Sirtuins family as a target in endothelial cell dysfunction: implications for vascular ageing. Biogerontology. 2020; 21(5):495-516. DOI: 10.1007/s10522-020-09873-z. View

14.

Campagna R, Pozzi V, Sartini D, Salvolini E, Brisigotti V, Molinelli E . Beyond Nicotinamide Metabolism: Potential Role of Nicotinamide -Methyltransferase as a Biomarker in Skin Cancers. Cancers (Basel). 2021; 13(19). PMC: 8508019. DOI: 10.3390/cancers13194943. View

15.

Lin Q, Zuo W, Liu Y, Wu K, Liu Q . NAD and cardiovascular diseases. Clin Chim Acta. 2021; 515:104-110. DOI: 10.1016/j.cca.2021.01.012. View

16.

Abdellatif M, Bugger H, Kroemer G, Sedej S . NAD and Vascular Dysfunction: From Mechanisms to Therapeutic Opportunities. J Lipid Atheroscler. 2022; 11(2):111-132. PMC: 9133775. DOI: 10.12997/jla.2022.11.2.111. View

17.

Campagna R, Pozzi V, Spinelli G, Sartini D, Milanese G, Galosi A . The Utility of Nicotinamide N-Methyltransferase as a Potential Biomarker to Predict the Oncological Outcomes for Urological Cancers: An Update. Biomolecules. 2021; 11(8). PMC: 8393883. DOI: 10.3390/biom11081214. View

18.

Acosta-Martinez M, Cabail M . The PI3K/Akt Pathway in Meta-Inflammation. Int J Mol Sci. 2022; 23(23). PMC: 9740745. DOI: 10.3390/ijms232315330. View

19.

Gao Y, van Haren M, Buijs N, Innocenti P, Zhang Y, Sartini D . Potent Inhibition of Nicotinamide -Methyltransferase by Alkene-Linked Bisubstrate Mimics Bearing Electron Deficient Aromatics. J Med Chem. 2021; 64(17):12938-12963. PMC: 8436214. DOI: 10.1021/acs.jmedchem.1c01094. View

20.

van Haren M, Zhang Y, Thijssen V, Buijs N, Gao Y, Mateuszuk L . Macrocyclic peptides as allosteric inhibitors of nicotinamide -methyltransferase (NNMT). RSC Chem Biol. 2021; 2(5):1546-1555. PMC: 8496086. DOI: 10.1039/d1cb00134e. View